Vasant Jadhav
49Patents
7h-index
67Co-inventors
72Inventor score
Filing activity: Aug 17, 2004 → Oct 8, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10233448B2 | Modified double-stranded RNA agents | Chemistry; Metallurgy | 21 | Active |
| US7935812B2 | RNA interference mediated inhibition of hepatitis C virus (HCV) expression using short interfering nucleic acid (siNA) | Chemistry; Metallurgy | 18 | Active |
| US10612027B2 | Modified double-stranded RNA agents | Chemistry; Metallurgy | 15 | Active |
| US7858769B2 | RNA interference mediated inhibition of gene expression using multifunctional short interfering nucleic acid (multifunctional siNA) | Chemistry; Metallurgy | 15 | Active |
| US7521184B2 | Detection and quantitation of nucleic acid molecules in biological samples | Emerging Cross-Sectional Technologies | 15 | Expired |
| US11504391B1 | Modified RNA agents with reduced off-target effect | Chemistry; Metallurgy | 12 | Active |
| US10208307B2 | Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases | Chemistry; Metallurgy | 11 | Active |
| US7517864B2 | RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) | Chemistry; Metallurgy | 7 | Expired |
| US10995336B2 | Serpina1 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US10513703B2 | Hepatitis B virus (HBV) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US10246713B2 | TMPRSS6 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US11286486B2 | Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases | Chemistry; Metallurgy | 4 | Active |
| US10612024B2 | Modified double-stranded RNA agents | Chemistry; Metallurgy | 4 | Active |
| US10689648B2 | Short interfering nucleic acid (siNA) compositions | Chemistry; Metallurgy | 4 | Active |
| US11597932B2 | Chirally-enriched double-stranded RNA agents | Chemistry; Metallurgy | 3 | Active |
| US10683501B2 | Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases | Chemistry; Metallurgy | 3 | Active |
| US10004814B2 | Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety | Chemistry; Metallurgy | 2 | Active |
| US10829763B2 | TMPRSS6 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US10729787B2 | Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety | Chemistry; Metallurgy | 2 | Active |
| US11060091B2 | Hepatitis B virus (HBV) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US11401517B2 | Modified double-stranded RNA agents | Chemistry; Metallurgy | 2 | Active |
| US11725207B2 | Serpina1 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US11492623B2 | Hepatitis B virus (HBV) dsRNA agent compositions and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US12168767B2 | Modified double-stranded RNA agents | Chemistry; Metallurgy | 0 | Active |
| US12275938B2 | Modified RNA agents with reduced off-target effect | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.